India
· Delayed Price · Currency is INR Rossari Biotech Statistics
Total Valuation
Rossari Biotech has a market cap or net worth of INR 39.01 billion. The enterprise value is 39.82 billion.
| Market Cap | 39.01B |
| Enterprise Value | 39.82B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
Rossari Biotech has 55.36 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 55.36M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 62.33% |
| Owned by Institutions (%) | 22.90% |
| Float | 17.62M |
Valuation Ratios
The trailing PE ratio is 28.67 and the forward PE ratio is 24.75. Rossari Biotech's PEG ratio is 1.77.
| PE Ratio | 28.67 |
| Forward PE | 24.75 |
| PS Ratio | 1.98 |
| PB Ratio | 3.49 |
| P/TBV Ratio | 4.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.77 |
Enterprise Valuation
| EV / Earnings | 29.26 |
| EV / Sales | 2.02 |
| EV / EBITDA | 16.15 |
| EV / EBIT | 20.98 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | n/a |
| Interest Coverage | 11.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.88% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 43.85M |
| Profits Per Employee | 3.02M |
| Employee Count | 450 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.12% in the last 52 weeks. The beta is 0.25, so Rossari Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -7.12% |
| 50-Day Moving Average | 645.92 |
| 200-Day Moving Average | 787.88 |
| Relative Strength Index (RSI) | 67.82 |
| Average Volume (20 Days) | 111,577 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rossari Biotech had revenue of INR 19.73 billion and earned 1.36 billion in profits. Earnings per share was 24.58.
| Revenue | 19.73B |
| Gross Profit | 5.96B |
| Operating Income | 1.89B |
| Pretax Income | 1.83B |
| Net Income | 1.36B |
| EBITDA | 2.44B |
| EBIT | 1.89B |
| Earnings Per Share (EPS) | 24.58 |
Balance Sheet
The company has 800.08 million in cash and 1.61 billion in debt, giving a net cash position of -807.73 million or -14.59 per share.
| Cash & Cash Equivalents | 800.08M |
| Total Debt | 1.61B |
| Net Cash | -807.73M |
| Net Cash Per Share | -14.59 |
| Equity (Book Value) | 11.18B |
| Book Value Per Share | 202.14 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.22%, with operating and profit margins of 9.57% and 6.89%.
| Gross Margin | 30.22% |
| Operating Margin | 9.57% |
| Pretax Margin | 9.28% |
| Profit Margin | 6.89% |
| EBITDA Margin | 12.38% |
| EBIT Margin | 9.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.07%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.04% |
| Earnings Yield | 3.49% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |